ArticleEuropean heart journal2026

Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries.

Raja Zaghlol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.